Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer.
about
Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trialRole of systemic inflammation scores in pulmonary metastasectomy for colorectal cancer.
P2860
Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated pre-treatment levels ...... tients with colorectal cancer.
@en
Elevated pre-treatment levels ...... tients with colorectal cancer.
@nl
type
label
Elevated pre-treatment levels ...... tients with colorectal cancer.
@en
Elevated pre-treatment levels ...... tients with colorectal cancer.
@nl
prefLabel
Elevated pre-treatment levels ...... tients with colorectal cancer.
@en
Elevated pre-treatment levels ...... tients with colorectal cancer.
@nl
P2093
P2860
P356
P1476
Elevated pre-treatment levels ...... tients with colorectal cancer.
@en
P2093
Hongzhang Shen
Junxing Huang
Maosong Lin
P2860
P304
P356
10.3892/ETM.2013.1350
P577
2013-10-16T00:00:00Z